https://fert-c.eeElite erakliinikElite erakliinik Tartus Sangla 63. Viljatusravi ja günekoloogid, 3D-4D ultraheli, endokrinoloog, nahaarstid, kõrva-nina-kurguarstid, onkoloogid jpm. erialad
Name
Formosus Capital OÜ
Registry code
12746975
VAT number
EE101769965
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.11.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
68201 - Rental and operating of own or leased real estate
114 759 €
-119 771 €
-104%
-
19 452 €
0
Submitted
No tax arrears
-616%
-12%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ FERTIILSUSE KESKUS 10240426 | 100% - 2 500.00 EUR | - | - | |
| Andrei Sõritsa 25.11.1961 (62) | - | Board member | Direct ownership | |
| Deniss Sõritsa 16.11.1982 (42) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Zenith Family Office OÜ 12097803 | - | - | - | Founder |
| 2019 29.06.2020 | 2020 30.06.2021 | 2021 28.06.2022 | 2022 29.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 96 015 € | 97 766 € | 107 174 € | 119 335 € | 114 759 € |
| Net profit (loss) for the period | -13 709 € | 7 563 € | -46 955 € | -77 969 € | -119 771 € |
| Profit Margin | -14% | 8% | -44% | -65% | -104% |
| Current Assets | 28 520 € | 23 727 € | 38 548 € | 41 420 € | 24 074 € |
| Fixed Assets | 755 418 € | 716 861 € | 882 693 € | 1 086 197 € | 993 632 € |
| Total Assets | 783 938 € | 740 588 € | 921 241 € | 1 127 617 € | 1 017 706 € |
| Current Liabilities | 71 271 € | 55 521 € | 81 779 € | 116 749 € | 97 407 € |
| Non Current Liabilities | 676 083 € | 640 920 € | 742 270 € | 991 645 € | 900 847 € |
| Total Liabilities | 747 354 € | 696 441 € | 824 049 € | 1 108 394 € | 998 254 € |
| Share Capital | - | - | - | - | - |
| Equity | 36 584 € | 44 147 € | 97 192 € | 19 223 € | 19 452 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 31 517.73 € | 9 163.22 € | 3 520.62 € | - |
| 2023 Q4 | 28 051.44 € | 9 002.58 € | 3 520.62 € | - |
| 2023 Q3 | 26 048.84 € | 9 351.44 € | 3 520.62 € | - |
| 2023 Q2 | 28 279.33 € | 9 069.72 € | 3 520.62 € | - |
| 2023 Q1 | 33 465.81 € | 8 284.02 € | 3 520.62 € | - |
| 2022 Q4 | 30 359.06 € | - | 3 116.36 € | - |
| 2022 Q3 | 26 527.81 € | 8 293.92 € | 2 914.23 € | - |
| 2022 Q2 | 29 441.58 € | - | 2 379.01 € | - |
| 2022 Q1 | 32 104.29 € | 6 018.17 € | 2 149.8 € | - |
| 2021 Q4 | 59 412.37 € | 13 999.44 € | 2 335.75 € | - |
| 2021 Q3 | 24 664.2 € | 6 723.99 € | 2 554.05 € | - |
| 2021 Q2 | 26 248.12 € | 7 328.89 € | 1 947.69 € | - |
| 2021 Q1 | 27 711.94 € | - | 1 174.75 € | - |
| 2020 Q4 | 25 720.84 € | 5 605.41 € | 788.28 € | - |
| 2020 Q3 | 24 699.06 € | 4 359.4 € | 788.28 € | - |
| 2020 Q2 | 23 452.78 € | 4 737.37 € | 788.28 € | - |
| 2020 Q1 | 20 828.57 € | 3 934.92 € | 788.28 € | - |
